Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences
Saint-Herblain (France), October 10, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today it...
Month: October 2022
Santhera and ReveraGen Announce Presentations on Long-Term Efficacy and Bone Health in DMD During Vamorolone Treatment at the 2022 World Muscle Society Congress
Pratteln, Switzerland, and Rockville, MD, USA, October 10, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of...
The Well Lounge Med Spa Announces the Launch of Their New Website
The Newtown-Based Med Spa Is Pleased to Announce That Their New Site Has Gone LiveNEWTOWN, Pa., Oct. 07, 2022 (GLOBE...
Agra Ventures Grants Restricted Share Units
VANCOUVER, British Columbia, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTC: AGFAF),...
RadioMedix announces a $40 million Series A financing for the advancement of novel Targeted Alpha Therapy platform and diagnostic companion radiopharmaceuticals to address unmet needs in oncology; Michael Lee-Chin appointed to the board of the company
HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) -- RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced...
XORTX Announces Closing of US$5 Million Public Offering
CALGARY, Alberta, Oct. 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
ProLynx announces initiation of Phase II clinical trial of its DNA-damaging agent PLX038 in patients with platinum-resistant Ovarian Cancer at the Mayo Clinic
SAN FRANCISCO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- ProLynx Inc. today announced that the first patient was treated with PLX038...
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
Topics to Include Continued Analysis of FDA’s Clinical Hold on IND for Cell-in-a-Box®LAS VEGAS, Oct. 07, 2022 (GLOBE NEWSWIRE) -- PharmaCyte...
Oncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of Cancer
New preclinical results support self-amplifying vRNA/LNP immunotherapy platform and ongoing IND-enabling studies of ONCR-021ANDOVER, Mass., Oct. 07, 2022 (GLOBE NEWSWIRE)...
Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices
Integration with the LIBERTY® Robotic System & One & Done™ Technology May Enable Future Acceleration of Robotic Adoption; Represents an...
Pharvaris Presents Data Supporting HAE Drug Development Strategy at the 2022 HAEi Global Leadership Workshop
ZUG, Switzerland, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to...
Sarepta Therapeutics Presents New Data from its Gene Therapy and RNA Platforms at World Muscle Society 2022
CAMBRIDGE, Mass., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM
LOS ANGELES, Oct. 07, 2022 (GLOBE NEWSWIRE) -- InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company...
Replimune Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
WOBURN, Mass., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the...
BridgeBio Pharma to Present New Data on its Novel Approaches to RAS-driven Cancers at the Fourth RAS Initiative Symposium
- The conference will take place at the National Cancer Institute at Frederick, Maryland from October 17-19, 2022 - Presentation...
Amendment of Short-Term Loan Facility into new Term Loan Facility With Oaktree
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market...
Ocuphire Pharma to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
Ocuphire to Present on Wednesday, October 12th @ 2:30 PM CTFARMINGTON HILLS, Mich., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Ocuphire...
CLS Americas Present Fusion-Guided Focal Laser Ablation Solution at Unio Health Partners Summit
Minimally-Invasive, High Precision Laser Focal Therapy Enables Treatment of Prostate Tumors in an Office or ClinicNEWPORT BEACH, Calif., Oct. 07,...
Tilray Brands’ First Quarter Fiscal Year 2023 Performance Affirms Global Cannabis Leadership
Reported Net Revenue at $153.2 Million; On a Constant Currency Basis, Net Revenue Remained Strong at $166.5 Million Cannabis Gross...
Cannalogue Accepts Payment by Visa Debit
New payment method for medical cannabis in CanadaTORONTO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Healthcare technology company, Cannalogue adopts new...